Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wright, S.D.; Busbridge, R.C.; Gard, G.B. A conservative and fertility preserving treatment for interstitial ectopic pregnancy. Aust. N. Z. J. Obstet. Gynaecol. 2013, 53, 211–213. [Google Scholar] [CrossRef]
- Brincat, M.; Bryant-Smith, A.; Holland, T.K. The diagnosis and management of interstitial ectopic pregnancies: A review. Gynecol. Surg. 2019, 16, 2. [Google Scholar] [CrossRef] [Green Version]
- Koukoura, O.; Dragoumis, G.; Gorila, G.; Gkorezi-Ntavela, I.; Dafopoulos, K.; Pistofidis, G. Spontaneous Intraoperative Rupture of a Large Interstitial Pregnancy: Laparoscopic Management. Case Rep. Obstet. Gynecol. 2020, 2020, 5626783. [Google Scholar] [CrossRef] [Green Version]
- Stabile, G.; Romano, F.; Buonomo, F.; Zinicola, G.; Ricci, G. Conservative Treatment of Interstitial Ectopic Pregnancy with the Combination of Mifepristone and Methotrexate: Our Experience and Review of the Literature. BioMed Res. Int. 2020, 2020, 8703496. [Google Scholar] [CrossRef]
- Moawad, N.; Mahajan, S.T.; Moniz, M.H.; Taylor, S.E.; Hurd, W.W. Current diagnosis and treatment of interstitial pregnancy. Am. J. Obstet. Gynecol. 2010, 202, 15–29. [Google Scholar] [CrossRef]
- Corioni, S.; Perelli, F.; Bianchi, C.; Cozzolino, M.; Maggio, L.; Masini, G.; Coccia, M.E. Interstitial pregnancy treated with a single-dose of systemic methotrexate: A successful management. J. Res. Med. Sci. 2015, 20, 312–316. [Google Scholar] [PubMed]
- Timor-Tritsch, I.E.; Monteagudo, A.; Matera, C.; Veit, C.R. Sonographic evolution of cornual pregnancies treated without surgery. Obstet. Gynecol. 1992, 79, 1044–1049. [Google Scholar]
- Jurkovic, D.; Mavrelos, D. Catch me if you scan: Ultrasound diagnosis of ectopic pregnancy. Ultrasound Obstet. Gynecol. 2007, 30, 1–7. [Google Scholar] [CrossRef]
- Narang, L.; Kalu, G. Laparoscopic salpingocentesis using methotrexate in combination with oral mifepristone for successful treatment of interstitial pregnancy: A case report. Fertil. Steril. 2009, 92, 2038.e5–2038.e7. [Google Scholar] [CrossRef] [PubMed]
- Taghiyar, L.; Khani, B.; Behnamfar, F. Which protocol is better for treatment of ectopic pregnancy by methotrexate? Single-dose or multiple-dose. Adv. Biomed. Res. 2020, 9, 59. [Google Scholar] [CrossRef] [PubMed]
- García, M.T.G.; Benitez, G.A.; Belda, B.B.; Rodríguez, C.C.; Merlo, G.G. Medical therapy (methotrexate and mifepristone) alone or in combination with another type of therapy for the management of cervical or interstitial ectopic pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012, 165, 77–81. [Google Scholar] [CrossRef]
- Stabile, G.; Zinicola, G.; Romano, F.; Buonomo, F.; Mangino, F.P.; Ricci, G. Management of Non-Tubal Ectopic Pregnancies: A Single Center Experience. Diagnostics 2020, 10, 652. [Google Scholar] [CrossRef]
- Garzon, S.; Laganà, A.S.; Pomini, P.; Raffaelli, R.; Ghezzi, F.; Franchi, M. Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim. Invasive Ther. Allied Technol. 2018, 28, 359–362. [Google Scholar] [CrossRef]
- Torre, A.; Paillusson, B.; Fain, V.; Labauge, P.; Pelage, J.P.; Fauconnier, A. Uterine artery embolization for severe symptomatic fibroids: Effects on fertility and symptoms. Hum. Reprod. 2014, 29, 490–501. [Google Scholar] [CrossRef] [Green Version]
- Tanaka, T.; Hayashi, H.; Kutsuzawa, T.; Fujimoto, S.; Ichinoe, K. Treatment of interstitial ectopic pregnancy with methotrexate: Report of a successful case. Fertil. Steril. 1982, 37, 851–852. [Google Scholar] [CrossRef]
- Bachman, E.A.; Barnhart, K. Medical Management of Ectopic Pregnancy. Clin. Obstet. Gynecol. 2012, 55, 440–447. [Google Scholar] [CrossRef] [Green Version]
- Jurkovic, D.; Memtsa, M.; Sawyer, E.; Donaldson, A.N.A.; Jamil, A.; Schramm, K.; Ana, D.; Otify, M.; Farahani, L.; Nunes, N.; et al. Single-dose systemic methotrexatevsexpectant management for treatment of tubal ectopic pregnancy: A placebo-controlled randomized trial. Ultrasound Obstet. Gynecol. 2017, 49, 171–176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hamed, H.O.; Ahmed, S.R.; Alghasham, A.A. Comparison of double- and single-dose methotrexate protocols for treatment of ectopic pregnancy. Int. J. Gynecol. Obstet. 2011, 116, 67–71. [Google Scholar] [CrossRef] [PubMed]
- Tulandi, T. Ectopic Pregnancy: Choosing a Treatment. Up to Date. 2020. Available online: https://www.uptodate.com/contents/ectopic-pregnancy-choosing-a-treatment (accessed on 6 June 2021).
- Barnhart, K.T. The medical management of ectopic pregnancy: A meta-analysis comparing “single dose” and “multidose” regimens. Obstet. Gynecol. 2003, 101, 778–784. [Google Scholar] [CrossRef]
- Yang, C.; Cai, J.; Geng, Y.; Gao, Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: A systematic review and meta-analysis. Reprod. Biomed. Online 2017, 34, 383–391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stabile, G.; Mangino, F.P.; Romano, F.; Zinicola, G.; Ricci, G. Ectopic Cervical Pregnancy: Treatment Route. Medicina 2020, 56, 293. [Google Scholar] [CrossRef]
- Perdu, M.; Camus, E.; Rozenberg, P.; Goffinet, F.; Chastang, C.; Philippe, H.-J.; Nisand, I. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: A phase II nonrandomized study. Am. J. Obstet. Gynecol. 1998, 179, 640–643. [Google Scholar] [CrossRef]
- DeHart, R.M.; Morehead, M.S. Mifepristone. Ann. Pharmacother. 2001, 35, 707–719. [Google Scholar] [CrossRef] [PubMed]
- Gomez García, M.T.; Del Cerro, E.L.; Selva, R.M.; Nogueira García, J.; CallejonRodríguez, C.; Gonzales Merlo, G. Indications of mifepristone in ectopic pregnancy. In Mifepristone: Pharmacology, Medical Uses and Potential Side Effects; Nova Science Publishers: Hauppauge, NY, USA, 2014; pp. 27–50. [Google Scholar]
- Karki, U.; Saha, R. Medical management of unruptured interstitial pregnancy with mifepristone and methotrexate. J. Kathmandu Med. Coll. 2016, 4, 34–36. [Google Scholar] [CrossRef] [Green Version]
- Garbin, O.; de Tayrac, R.; de Poncheville, L.; Coiffic, J.; Lucot, J.-P.; Le Goueff, F.; Tardif, D.; Allouche, C.; Camus, E.; Chevret, S.; et al. Traitement médical des grossesses extra-utérines: Un essai clinique randomisé comparant méthotrexate-mifépristone et placebo-méthotrexate. J. Gynécologie Obs. Biol. Reprod. 2004, 33, 391–400. [Google Scholar] [CrossRef]
- Osada, H.; Teramoto, S.; Kaijima, H.; Segawa, T.; Nagaishi, M.; Shozu, M.; Kato, K. Managing Ectopic Pregnancies by Targeting Chorionic Villi with a Transvaginal Injection of Ethanol into the Lacunar Space. Biomedicines 2020, 8, 202. [Google Scholar] [CrossRef] [PubMed]
Reference | Pregnancy Hystory | GA | Embryo (CRL mm) | FHB | Basal β-hCG mUi/mL | Management |
---|---|---|---|---|---|---|
Current Case | G2P0 (1 Previous EP treated by LPS: monolateral salpingectomy) | 7 weeks | 9 | + | 22,272 | Mifepristone 600 mg + MTX 1 mg/kg + 0. 1 mg folinic acid (four doses) |
Case 1 Stabile G. et al. 2020 [4] | G1P0 | 7 weeks | 3.6 | + | 19,397 | Mifepristone 600 mg + MTX 1 mg/kg + 0.1 mg folinic acid (single dose) |
Case 2 Stabile G. et al. 2020 [4] | G2P1 | 6 weeks + 6 days | no embryo | − | 2664 | Mifepristone 600 mg + MTX 50 mg/m2 of body surface (double dose) |
Case 3 Gomez Garcia et al. 2012 [8] | G2P1 | 8 weeks +3 days | no embryo | − | 3724 | Mifepristone 600 mg + IM MTX 50 mg/m2 of body surface (single dose) |
Case 4 Gomez Garcia et al. 2012 [8] | G4P0 (3 VIPs) | 6 weeks + 3 days | 6 | − | 4116 | Oral mifepristone 600 mg + IM MTX 50 mg/m2 of body surface (single dose) |
Case 5 Stabile G. et al. 2020 [9] | G3P1 | 6 weeks | no embryo | − | 6579 | Mifepristone 600 mg + MTX 50 mg/m2 of body surface (single dose) |
Case 6 Stabile G. et al. 2020 [9] | G3P1 | 5 weeks + 3 days | no embryo | − | 2124 | Mifepristone 600 mg + MTX 50 mg/m2 of body surface (single dose) |
Case 7 Karki et al. 2015 [10] | G1P0 | 5 weeks + 1 day | no embryo | − | 594.8 | Oral mifepristone 200 mg + IM MTX 50 mg/m2 of body surface (single dose) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Stabile, G.; Romano, F.; Zinicola, G.; Topouzova, G.A.; Di Lorenzo, G.; Mangino, F.P.; Ricci, G. Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment. Int. J. Environ. Res. Public Health 2021, 18, 9781. https://doi.org/10.3390/ijerph18189781
Stabile G, Romano F, Zinicola G, Topouzova GA, Di Lorenzo G, Mangino FP, Ricci G. Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment. International Journal of Environmental Research and Public Health. 2021; 18(18):9781. https://doi.org/10.3390/ijerph18189781
Chicago/Turabian StyleStabile, Guglielmo, Federico Romano, Giulia Zinicola, Ghergana Alexandrova Topouzova, Giovanni Di Lorenzo, Francesco Paolo Mangino, and Giuseppe Ricci. 2021. "Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment" International Journal of Environmental Research and Public Health 18, no. 18: 9781. https://doi.org/10.3390/ijerph18189781